Global Integrin Alpha 4 Market Growth 2025-2031

January 2025 | 106 pages | ID: G1F7C2F22C77EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Integrin Alpha 4 market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for Integrin Alpha 4 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Integrin Alpha 4 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Integrin Alpha 4 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Integrin Alpha 4 players cover Amgen Inc, Antisense Therapeutics Ltd, Biogen Inc, BioMAS Ltd, Daiichi Sankyo Co Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Integrin Alpha 4 Industry Forecast” looks at past sales and reviews total world Integrin Alpha 4 sales in 2024, providing a comprehensive analysis by region and market sector of projected Integrin Alpha 4 sales for 2025 through 2031. With Integrin Alpha 4 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Integrin Alpha 4 industry.

This Insight Report provides a comprehensive analysis of the global Integrin Alpha 4 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Integrin Alpha 4 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Integrin Alpha 4 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Integrin Alpha 4 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Integrin Alpha 4.

This report presents a comprehensive overview, market shares, and growth opportunities of Integrin Alpha 4 market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• TE-5232
• ATL-1102
• Carotegrast
• ET-3764
• Others

Segmentation by Application:

• Acute Ischemic Stroke
• Celiac Disease
• Epilepsy
• Melanoma
• Multiple Sclerosis
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Amgen Inc
• Antisense Therapeutics Ltd
• Biogen Inc
• BioMAS Ltd
• Daiichi Sankyo Co Ltd
• EA Pharma Co Ltd
• Immunwork Inc
• Morphic Therapeutic Inc
• Protagonist Therapeutics Inc
• Takeda Pharmaceutical Co Ltd
• Viriom Inc

Key Questions Addressed in this Report

What is the 10-year outlook for the global Integrin Alpha 4 market?

What factors are driving Integrin Alpha 4 market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Integrin Alpha 4 market opportunities vary by end market size?

How does Integrin Alpha 4 break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Integrin Alpha 4 Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Integrin Alpha 4 by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Integrin Alpha 4 by Country/Region, 2020, 2024 & 2031
2.2 Integrin Alpha 4 Segment by Type
  2.2.1 TE-5232
  2.2.2 ATL-1102
  2.2.3 Carotegrast
  2.2.4 ET-3764
  2.2.5 Others
2.3 Integrin Alpha 4 Sales by Type
  2.3.1 Global Integrin Alpha 4 Sales Market Share by Type (2020-2025)
  2.3.2 Global Integrin Alpha 4 Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Integrin Alpha 4 Sale Price by Type (2020-2025)
2.4 Integrin Alpha 4 Segment by Application
  2.4.1 Acute Ischemic Stroke
  2.4.2 Celiac Disease
  2.4.3 Epilepsy
  2.4.4 Melanoma
  2.4.5 Multiple Sclerosis
  2.4.6 Other
2.5 Integrin Alpha 4 Sales by Application
  2.5.1 Global Integrin Alpha 4 Sale Market Share by Application (2020-2025)
  2.5.2 Global Integrin Alpha 4 Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Integrin Alpha 4 Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Integrin Alpha 4 Breakdown Data by Company
  3.1.1 Global Integrin Alpha 4 Annual Sales by Company (2020-2025)
  3.1.2 Global Integrin Alpha 4 Sales Market Share by Company (2020-2025)
3.2 Global Integrin Alpha 4 Annual Revenue by Company (2020-2025)
  3.2.1 Global Integrin Alpha 4 Revenue by Company (2020-2025)
  3.2.2 Global Integrin Alpha 4 Revenue Market Share by Company (2020-2025)
3.3 Global Integrin Alpha 4 Sale Price by Company
3.4 Key Manufacturers Integrin Alpha 4 Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Integrin Alpha 4 Product Location Distribution
  3.4.2 Players Integrin Alpha 4 Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR INTEGRIN ALPHA 4 BY GEOGRAPHIC REGION

4.1 World Historic Integrin Alpha 4 Market Size by Geographic Region (2020-2025)
  4.1.1 Global Integrin Alpha 4 Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Integrin Alpha 4 Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Integrin Alpha 4 Market Size by Country/Region (2020-2025)
  4.2.1 Global Integrin Alpha 4 Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Integrin Alpha 4 Annual Revenue by Country/Region (2020-2025)
4.3 Americas Integrin Alpha 4 Sales Growth
4.4 APAC Integrin Alpha 4 Sales Growth
4.5 Europe Integrin Alpha 4 Sales Growth
4.6 Middle East & Africa Integrin Alpha 4 Sales Growth

5 AMERICAS

5.1 Americas Integrin Alpha 4 Sales by Country
  5.1.1 Americas Integrin Alpha 4 Sales by Country (2020-2025)
  5.1.2 Americas Integrin Alpha 4 Revenue by Country (2020-2025)
5.2 Americas Integrin Alpha 4 Sales by Type (2020-2025)
5.3 Americas Integrin Alpha 4 Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Integrin Alpha 4 Sales by Region
  6.1.1 APAC Integrin Alpha 4 Sales by Region (2020-2025)
  6.1.2 APAC Integrin Alpha 4 Revenue by Region (2020-2025)
6.2 APAC Integrin Alpha 4 Sales by Type (2020-2025)
6.3 APAC Integrin Alpha 4 Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Integrin Alpha 4 by Country
  7.1.1 Europe Integrin Alpha 4 Sales by Country (2020-2025)
  7.1.2 Europe Integrin Alpha 4 Revenue by Country (2020-2025)
7.2 Europe Integrin Alpha 4 Sales by Type (2020-2025)
7.3 Europe Integrin Alpha 4 Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Integrin Alpha 4 by Country
  8.1.1 Middle East & Africa Integrin Alpha 4 Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Integrin Alpha 4 Revenue by Country (2020-2025)
8.2 Middle East & Africa Integrin Alpha 4 Sales by Type (2020-2025)
8.3 Middle East & Africa Integrin Alpha 4 Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Integrin Alpha
10.3 Manufacturing Process Analysis of Integrin Alpha
10.4 Industry Chain Structure of Integrin Alpha

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Integrin Alpha 4 Distributors
11.3 Integrin Alpha 4 Customer

12 WORLD FORECAST REVIEW FOR INTEGRIN ALPHA 4 BY GEOGRAPHIC REGION

12.1 Global Integrin Alpha 4 Market Size Forecast by Region
  12.1.1 Global Integrin Alpha 4 Forecast by Region (2026-2031)
  12.1.2 Global Integrin Alpha 4 Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Integrin Alpha 4 Forecast by Type (2026-2031)
12.7 Global Integrin Alpha 4 Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Amgen Inc
  13.1.1 Amgen Inc Company Information
  13.1.2 Amgen Inc Integrin Alpha 4 Product Portfolios and Specifications
  13.1.3 Amgen Inc Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Amgen Inc Main Business Overview
  13.1.5 Amgen Inc Latest Developments
13.2 Antisense Therapeutics Ltd
  13.2.1 Antisense Therapeutics Ltd Company Information
  13.2.2 Antisense Therapeutics Ltd Integrin Alpha 4 Product Portfolios and Specifications
  13.2.3 Antisense Therapeutics Ltd Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Antisense Therapeutics Ltd Main Business Overview
  13.2.5 Antisense Therapeutics Ltd Latest Developments
13.3 Biogen Inc
  13.3.1 Biogen Inc Company Information
  13.3.2 Biogen Inc Integrin Alpha 4 Product Portfolios and Specifications
  13.3.3 Biogen Inc Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Biogen Inc Main Business Overview
  13.3.5 Biogen Inc Latest Developments
13.4 BioMAS Ltd
  13.4.1 BioMAS Ltd Company Information
  13.4.2 BioMAS Ltd Integrin Alpha 4 Product Portfolios and Specifications
  13.4.3 BioMAS Ltd Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 BioMAS Ltd Main Business Overview
  13.4.5 BioMAS Ltd Latest Developments
13.5 Daiichi Sankyo Co Ltd
  13.5.1 Daiichi Sankyo Co Ltd Company Information
  13.5.2 Daiichi Sankyo Co Ltd Integrin Alpha 4 Product Portfolios and Specifications
  13.5.3 Daiichi Sankyo Co Ltd Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Daiichi Sankyo Co Ltd Main Business Overview
  13.5.5 Daiichi Sankyo Co Ltd Latest Developments
13.6 EA Pharma Co Ltd
  13.6.1 EA Pharma Co Ltd Company Information
  13.6.2 EA Pharma Co Ltd Integrin Alpha 4 Product Portfolios and Specifications
  13.6.3 EA Pharma Co Ltd Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 EA Pharma Co Ltd Main Business Overview
  13.6.5 EA Pharma Co Ltd Latest Developments
13.7 Immunwork Inc
  13.7.1 Immunwork Inc Company Information
  13.7.2 Immunwork Inc Integrin Alpha 4 Product Portfolios and Specifications
  13.7.3 Immunwork Inc Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Immunwork Inc Main Business Overview
  13.7.5 Immunwork Inc Latest Developments
13.8 Morphic Therapeutic Inc
  13.8.1 Morphic Therapeutic Inc Company Information
  13.8.2 Morphic Therapeutic Inc Integrin Alpha 4 Product Portfolios and Specifications
  13.8.3 Morphic Therapeutic Inc Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Morphic Therapeutic Inc Main Business Overview
  13.8.5 Morphic Therapeutic Inc Latest Developments
13.9 Protagonist Therapeutics Inc
  13.9.1 Protagonist Therapeutics Inc Company Information
  13.9.2 Protagonist Therapeutics Inc Integrin Alpha 4 Product Portfolios and Specifications
  13.9.3 Protagonist Therapeutics Inc Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Protagonist Therapeutics Inc Main Business Overview
  13.9.5 Protagonist Therapeutics Inc Latest Developments
13.10 Takeda Pharmaceutical Co Ltd
  13.10.1 Takeda Pharmaceutical Co Ltd Company Information
  13.10.2 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Product Portfolios and Specifications
  13.10.3 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Takeda Pharmaceutical Co Ltd Main Business Overview
  13.10.5 Takeda Pharmaceutical Co Ltd Latest Developments
13.11 Viriom Inc
  13.11.1 Viriom Inc Company Information
  13.11.2 Viriom Inc Integrin Alpha 4 Product Portfolios and Specifications
  13.11.3 Viriom Inc Integrin Alpha 4 Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 Viriom Inc Main Business Overview
  13.11.5 Viriom Inc Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Integrin Alpha 4 Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Integrin Alpha 4 Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTE-5232
Table 4. Major Players of ATL-1102
Table 5. Major Players of Carotegrast
Table 6. Major Players of ET-3764
Table 7. Major Players of Others
Table 8. Global Integrin Alpha 4 Sales byType (2020-2025) & (K Pcs)
Table 9. Global Integrin Alpha 4 Sales Market Share byType (2020-2025)
Table 10. Global Integrin Alpha 4 Revenue byType (2020-2025) & ($ million)
Table 11. Global Integrin Alpha 4 Revenue Market Share byType (2020-2025)
Table 12. Global Integrin Alpha 4 Sale Price byType (2020-2025) & (USD/Pcs)
Table 13. Global Integrin Alpha 4 Sale by Application (2020-2025) & (K Pcs)
Table 14. Global Integrin Alpha 4 Sale Market Share by Application (2020-2025)
Table 15. Global Integrin Alpha 4 Revenue by Application (2020-2025) & ($ million)
Table 16. Global Integrin Alpha 4 Revenue Market Share by Application (2020-2025)
Table 17. Global Integrin Alpha 4 Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global Integrin Alpha 4 Sales by Company (2020-2025) & (K Pcs)
Table 19. Global Integrin Alpha 4 Sales Market Share by Company (2020-2025)
Table 20. Global Integrin Alpha 4 Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Integrin Alpha 4 Revenue Market Share by Company (2020-2025)
Table 22. Global Integrin Alpha 4 Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers Integrin Alpha 4 Producing Area Distribution and Sales Area
Table 24. Players Integrin Alpha 4 Products Offered
Table 25. Integrin Alpha 4 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Integrin Alpha 4 Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global Integrin Alpha 4 Sales Market Share Geographic Region (2020-2025)
Table 30. Global Integrin Alpha 4 Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Integrin Alpha 4 Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Integrin Alpha 4 Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global Integrin Alpha 4 Sales Market Share by Country/Region (2020-2025)
Table 34. Global Integrin Alpha 4 Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Integrin Alpha 4 Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Integrin Alpha 4 Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas Integrin Alpha 4 Sales Market Share by Country (2020-2025)
Table 38. Americas Integrin Alpha 4 Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Integrin Alpha 4 Sales byType (2020-2025) & (K Pcs)
Table 40. Americas Integrin Alpha 4 Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC Integrin Alpha 4 Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC Integrin Alpha 4 Sales Market Share by Region (2020-2025)
Table 43. APAC Integrin Alpha 4 Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Integrin Alpha 4 Sales byType (2020-2025) & (K Pcs)
Table 45. APAC Integrin Alpha 4 Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe Integrin Alpha 4 Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe Integrin Alpha 4 Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Integrin Alpha 4 Sales byType (2020-2025) & (K Pcs)
Table 49. Europe Integrin Alpha 4 Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Integrin Alpha 4 Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Integrin Alpha 4 Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Integrin Alpha 4 Sales byType (2020-2025) & (K Pcs)
Table 53. Middle East & Africa Integrin Alpha 4 Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of Integrin Alpha 4
Table 55. Key Market Challenges & Risks of Integrin Alpha 4
Table 56. Key IndustryTrends of Integrin Alpha 4
Table 57. Integrin Alpha 4 Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Integrin Alpha 4 Distributors List
Table 60. Integrin Alpha 4 Customer List
Table 61. Global Integrin Alpha 4 SalesForecast by Region (2026-2031) & (K Pcs)
Table 62. Global Integrin Alpha 4 RevenueForecast by Region (2026-2031) & ($ millions)
Table 63. Americas Integrin Alpha 4 SalesForecast by Country (2026-2031) & (K Pcs)
Table 64. Americas Integrin Alpha 4 Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 65. APAC Integrin Alpha 4 SalesForecast by Region (2026-2031) & (K Pcs)
Table 66. APAC Integrin Alpha 4 Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 67. Europe Integrin Alpha 4 SalesForecast by Country (2026-2031) & (K Pcs)
Table 68. Europe Integrin Alpha 4 RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Integrin Alpha 4 SalesForecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa Integrin Alpha 4 RevenueForecast by Country (2026-2031) & ($ millions)
Table 71. Global Integrin Alpha 4 SalesForecast byType (2026-2031) & (K Pcs)
Table 72. Global Integrin Alpha 4 RevenueForecast byType (2026-2031) & ($ millions)
Table 73. Global Integrin Alpha 4 SalesForecast by Application (2026-2031) & (K Pcs)
Table 74. Global Integrin Alpha 4 RevenueForecast by Application (2026-2031) & ($ millions)
Table 75. Amgen Inc Basic Information, Integrin Alpha 4 Manufacturing Base, Sales Area and Its Competitors
Table 76. Amgen Inc Integrin Alpha 4 Product Portfolios and Specifications
Table 77. Amgen Inc Integrin Alpha 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Amgen Inc Main Business
Table 79. Amgen Inc Latest Developments
Table 80. AntisenseTherapeutics Ltd Basic Information, Integrin Alpha 4 Manufacturing Base, Sales Area and Its Competitors
Table 81. AntisenseTherapeutics Ltd Integrin Alpha 4 Product Portfolios and Specifications
Table 82. AntisenseTherapeutics Ltd Integrin Alpha 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. AntisenseTherapeutics Ltd Main Business
Table 84. AntisenseTherapeutics Ltd Latest Developments
Table 85. Biogen Inc Basic Information, Integrin Alpha 4 Manufacturing Base, Sales Area and Its Competitors
Table 86. Biogen Inc Integrin Alpha 4 Product Portfolios and Specifications
Table 87. Biogen Inc Integrin Alpha 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Biogen Inc Main Business
Table 89. Biogen Inc Latest Developments
Table 90. BioMAS Ltd Basic Information, Integrin Alpha 4 Manufacturing Base, Sales Area and Its Competitors
Table 91. BioMAS Ltd Integrin Alpha 4 Product Portfolios and Specifications
Table 92. BioMAS Ltd Integrin Alpha 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. BioMAS Ltd Main Business
Table 94. BioMAS Ltd Latest Developments
Table 95. Daiichi Sankyo Co Ltd Basic Information, Integrin Alpha 4 Manufacturing Base, Sales Area and Its Competitors
Table 96. Daiichi Sankyo Co Ltd Integrin Alpha 4 Product Portfolios and Specifications
Table 97. Daiichi Sankyo Co Ltd Integrin Alpha 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Daiichi Sankyo Co Ltd Main Business
Table 99. Daiichi Sankyo Co Ltd Latest Developments
Table 100. EA Pharma Co Ltd Basic Information, Integrin Alpha 4 Manufacturing Base, Sales Area and Its Competitors
Table 101. EA Pharma Co Ltd Integrin Alpha 4 Product Portfolios and Specifications
Table 102. EA Pharma Co Ltd Integrin Alpha 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. EA Pharma Co Ltd Main Business
Table 104. EA Pharma Co Ltd Latest Developments
Table 105. Immunwork Inc Basic Information, Integrin Alpha 4 Manufacturing Base, Sales Area and Its Competitors
Table 106. Immunwork Inc Integrin Alpha 4 Product Portfolios and Specifications
Table 107. Immunwork Inc Integrin Alpha 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Immunwork Inc Main Business
Table 109. Immunwork Inc Latest Developments
Table 110. MorphicTherapeutic Inc Basic Information, Integrin Alpha 4 Manufacturing Base, Sales Area and Its Competitors
Table 111. MorphicTherapeutic Inc Integrin Alpha 4 Product Portfolios and Specifications
Table 112. MorphicTherapeutic Inc Integrin Alpha 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. MorphicTherapeutic Inc Main Business
Table 114. MorphicTherapeutic Inc Latest Developments
Table 115. ProtagonistTherapeutics Inc Basic Information, Integrin Alpha 4 Manufacturing Base, Sales Area and Its Competitors
Table 116. ProtagonistTherapeutics Inc Integrin Alpha 4 Product Portfolios and Specifications
Table 117. ProtagonistTherapeutics Inc Integrin Alpha 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. ProtagonistTherapeutics Inc Main Business
Table 119. ProtagonistTherapeutics Inc Latest Developments
Table 120.Takeda Pharmaceutical Co Ltd Basic Information, Integrin Alpha 4 Manufacturing Base, Sales Area and Its Competitors
Table 121.Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Product Portfolios and Specifications
Table 122.Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123.Takeda Pharmaceutical Co Ltd Main Business
Table 124.Takeda Pharmaceutical Co Ltd Latest Developments
Table 125. Viriom Inc Basic Information, Integrin Alpha 4 Manufacturing Base, Sales Area and Its Competitors
Table 126. Viriom Inc Integrin Alpha 4 Product Portfolios and Specifications
Table 127. Viriom Inc Integrin Alpha 4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Viriom Inc Main Business
Table 129. Viriom Inc Latest Developments



LIST OFFIGURES

Figure 1. Picture of Integrin Alpha 4
Figure 2. Integrin Alpha 4 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Integrin Alpha 4 Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Integrin Alpha 4 Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Integrin Alpha 4 Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Integrin Alpha 4 Sales Market Share by Country/Region (2024)
Figure 10. Integrin Alpha 4 Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofTE-5232
Figure 12. Product Picture of ATL-1102
Figure 13. Product Picture of Carotegrast
Figure 14. Product Picture of ET-3764
Figure 15. Product Picture of Others
Figure 16. Global Integrin Alpha 4 Sales Market Share byType in 2025
Figure 17. Global Integrin Alpha 4 Revenue Market Share byType (2020-2025)
Figure 18. Integrin Alpha 4 Consumed in Acute Ischemic Stroke
Figure 19. Global Integrin Alpha 4 Market: Acute Ischemic Stroke (2020-2025) & (K Pcs)
Figure 20. Integrin Alpha 4 Consumed in Celiac Disease
Figure 21. Global Integrin Alpha 4 Market: Celiac Disease (2020-2025) & (K Pcs)
Figure 22. Integrin Alpha 4 Consumed in Epilepsy
Figure 23. Global Integrin Alpha 4 Market: Epilepsy (2020-2025) & (K Pcs)
Figure 24. Integrin Alpha 4 Consumed in Melanoma
Figure 25. Global Integrin Alpha 4 Market: Melanoma (2020-2025) & (K Pcs)
Figure 26. Integrin Alpha 4 Consumed in Multiple Sclerosis
Figure 27. Global Integrin Alpha 4 Market: Multiple Sclerosis (2020-2025) & (K Pcs)
Figure 28. Integrin Alpha 4 Consumed in Other
Figure 29. Global Integrin Alpha 4 Market: Other (2020-2025) & (K Pcs)
Figure 30. Global Integrin Alpha 4 Sale Market Share by Application (2024)
Figure 31. Global Integrin Alpha 4 Revenue Market Share by Application in 2025
Figure 32. Integrin Alpha 4 Sales by Company in 2025 (K Pcs)
Figure 33. Global Integrin Alpha 4 Sales Market Share by Company in 2025
Figure 34. Integrin Alpha 4 Revenue by Company in 2025 ($ millions)
Figure 35. Global Integrin Alpha 4 Revenue Market Share by Company in 2025
Figure 36. Global Integrin Alpha 4 Sales Market Share by Geographic Region (2020-2025)
Figure 37. Global Integrin Alpha 4 Revenue Market Share by Geographic Region in 2025
Figure 38. Americas Integrin Alpha 4 Sales 2020-2025 (K Pcs)
Figure 39. Americas Integrin Alpha 4 Revenue 2020-2025 ($ millions)
Figure 40. APAC Integrin Alpha 4 Sales 2020-2025 (K Pcs)
Figure 41. APAC Integrin Alpha 4 Revenue 2020-2025 ($ millions)
Figure 42. Europe Integrin Alpha 4 Sales 2020-2025 (K Pcs)
Figure 43. Europe Integrin Alpha 4 Revenue 2020-2025 ($ millions)
Figure 44. Middle East & Africa Integrin Alpha 4 Sales 2020-2025 (K Pcs)
Figure 45. Middle East & Africa Integrin Alpha 4 Revenue 2020-2025 ($ millions)
Figure 46. Americas Integrin Alpha 4 Sales Market Share by Country in 2025
Figure 47. Americas Integrin Alpha 4 Revenue Market Share by Country (2020-2025)
Figure 48. Americas Integrin Alpha 4 Sales Market Share byType (2020-2025)
Figure 49. Americas Integrin Alpha 4 Sales Market Share by Application (2020-2025)
Figure 50. United States Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 51. Canada Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 52. Mexico Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 53. Brazil Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 54. APAC Integrin Alpha 4 Sales Market Share by Region in 2025
Figure 55. APAC Integrin Alpha 4 Revenue Market Share by Region (2020-2025)
Figure 56. APAC Integrin Alpha 4 Sales Market Share byType (2020-2025)
Figure 57. APAC Integrin Alpha 4 Sales Market Share by Application (2020-2025)
Figure 58. China Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 59. Japan Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 60. South Korea Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 61. Southeast Asia Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 62. India Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 63. Australia Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 64. ChinaTaiwan Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 65. Europe Integrin Alpha 4 Sales Market Share by Country in 2025
Figure 66. Europe Integrin Alpha 4 Revenue Market Share by Country (2020-2025)
Figure 67. Europe Integrin Alpha 4 Sales Market Share byType (2020-2025)
Figure 68. Europe Integrin Alpha 4 Sales Market Share by Application (2020-2025)
Figure 69. Germany Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 70.France Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 71. UK Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 72. Italy Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 73. Russia Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 74. Middle East & Africa Integrin Alpha 4 Sales Market Share by Country (2020-2025)
Figure 75. Middle East & Africa Integrin Alpha 4 Sales Market Share byType (2020-2025)
Figure 76. Middle East & Africa Integrin Alpha 4 Sales Market Share by Application (2020-2025)
Figure 77. Egypt Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 78. South Africa Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 79. Israel Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 80.Turkey Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 81. GCC Countries Integrin Alpha 4 Revenue Growth 2020-2025 ($ millions)
Figure 82. Manufacturing Cost Structure Analysis of Integrin Alpha 4 in 2025
Figure 83. Manufacturing Process Analysis of Integrin Alpha 4
Figure 84. Industry Chain Structure of Integrin Alpha 4
Figure 85. Channels of Distribution
Figure 86. Global Integrin Alpha 4 Sales MarketForecast by Region (2026-2031)
Figure 87. Global Integrin Alpha 4 Revenue Market ShareForecast by Region (2026-2031)
Figure 88. Global Integrin Alpha 4 Sales Market ShareForecast byType (2026-2031)
Figure 89. Global Integrin Alpha 4 Revenue Market ShareForecast byType (2026-2031)
Figure 90. Global Integrin Alpha 4 Sales Market ShareForecast by Application (2026-2031)
Figure 91. Global Integrin Alpha 4 Revenue Market ShareForecast by Application (2026-2031)